Paper · 7954786

Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle.

Peter M and 1 other. Cell, 1994. Cited by 469 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Papers, record 7954786. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7954786

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle.; PubMed
Journal: Cell; PubMed
Year: 1994; PubMed
Publication types: Comment, Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/7954786/; PubMed
DOI: https://doi.org/10.1016/0092-8674(94)90186-4; PubMed
The journal: https://conductscience.org/library/journal-index/0413066; PubMed
Citations, by iCite: 469; iCite
Relative citation ratio, by iCite: 9.53; iCite
Revised in PubMed: 2024-01-09; PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Peter M	M
2	Herskowitz I	I

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Cell Cycle	Major topic
Cyclin-Dependent Kinases	Major topic
Cyclins	Major topic
Animals
Cyclin-Dependent Kinase Inhibitor p21
Humans
Macromolecular Substances

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

Kind	PMID	Title	In Papers
Comment on	7,954,792	The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae.	https://conductscience.org/library/papers/7954792

Source PubMed

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by93

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 469 citations.

PMID	Title	Journal	Year	In Papers	Source
40,159,425	Moderate levels of dissolved iron stimulate cellular growth and increase lipid storage in Symbiodinium sp.	J Phycol	2025	https://conductscience.org/library/papers/40159425	PubMed
39,093,881	Modeling the START transition in the budding yeast cell cycle.	PLoS Comput Biol	2024	https://conductscience.org/library/papers/39093881	PubMed
37,187,758	The roles of ERIANIN in tumor and innate immunity and its' perspectives in immunotherapy.	Front Immunol	2023	https://conductscience.org/library/papers/37187758	PubMed
36,269,137	KLF7 promotes preadipocyte proliferation via activation of the Akt signaling pathway by Cis-regulating CDKN3.	Acta Biochim Biophys Sin (Shanghai)	2022	https://conductscience.org/library/papers/36269137	PubMed
31,175,490	Boolean gene regulatory network model of centromere function in Saccharomyces cerevisiae.	J Biol Phys	2019	https://conductscience.org/library/papers/31175490	PubMed
27,172,794	EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.	Oncotarget	2016	https://conductscience.org/library/papers/27172794	PubMed
24,710,090	Role of Cell Division Autoantigen 1 (CDA1) in Cell Proliferation and Fibrosis.	Genes (Basel)	2010	https://conductscience.org/library/papers/24710090	PubMed
24,179,382	Promoter methylation in prostate cancer and its application for the early detection of prostate cancer using serum and urine samples.	Biomark Cancer	2010	https://conductscience.org/library/papers/24179382	PubMed
22,522,186	Developing peptide-based multivalent antagonists of proliferating cell nuclear antigen and a fluorescence-based PCNA binding assay.	Anal Biochem	2012	https://conductscience.org/library/papers/22522186	PubMed
22,108,861	RNAi targeting CXCR4 inhibits tumor growth through inducing cell cycle arrest and apoptosis.	Mol Ther	2012	https://conductscience.org/library/papers/22108861	PubMed

1 to 10 of 93

See all 93 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7954786

GET https://conductscience.org/api/papers/v1/7954786/cited_by?page=2

API reference For AI assistants